We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 26

The Italian Antitrust Authority rules that Merck group must grant royalty-free licenses of its patented active ingredient finasteride

  • Bird & Bird
  • -
  • Italy
  • -
  • May 29 2007

On 21 March 2007, the Italian Antitrust Authority (the “Authority”) has ruled that Merck & Co. and Merck Sharp & Dohme S.p.A. (together “Merck”) must grant licenses royalty-free under its Supplementary Protection Certificate (“SPC”) covering the active ingredient Finasteride and its presentation in tablets of 5 mg for the treatment of benign prostate hyperplasia (the “Product”

OFT launches study into the distribution of medicines in the UK

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • May 29 2007

Following proposed changes to the model by which UK pharmaceuticals companies distribute their medicines, the OFT has launched a short market study into the distribution of medicines in the UK

NMa fines two cartels in Dutch home care industry

  • Bird & Bird
  • -
  • Netherlands
  • -
  • January 23 2009

The Netherlands Competition Authority (NMa) has imposed fines, varying between 611,000 and 4 million Euros, on five home care providers in the Dutch regions of Kennemerland and ‘t Gooi for involvement in cartel activities

Commission launches sector inquiry into pharmaceuticals with unannounced inspections

  • Bird & Bird
  • -
  • European Union
  • -
  • February 7 2008

The European Commission has launched a sector inquiry into competition in the pharmaceuticals sector (under Article 17 of Regulation 12003), and is conducting inspections at the premises of a number of innovative and generic pharmaceutical companies

European Commission’s pharmaceutical sector inquiry final report

  • Bird & Bird
  • -
  • European Union
  • -
  • September 25 2009

In July 2009, the European Commission published its final report in its pharmaceutical sector inquiry, which was launched in January 2008

Advocate General’s opinion supporting parallel trade in Greek case against GSK

  • Bird & Bird
  • -
  • European Union, Greece
  • -
  • May 7 2008

The long running saga of disputes between Greek exporter wholesalers and GSK following GSK’s refusal of supplies for export purposes has taken a new turn

European Commission launches pharmaceutical investigation

  • Bird & Bird
  • -
  • European Union
  • -
  • May 7 2008

The European Commission has, using its investigatory powers under Article 17 of Regulation 12003, launched an inquiry into competition in the pharmaceuticals sector

The Competition Council condemns seven doctors’ unions for concerted practices in the medical sector

  • Bird & Bird
  • -
  • France
  • -
  • May 27 2008

On 2 April 2008, the Competition Council, which had received a complaint from a consumers association, condemned seven doctors’ unions for concerted practices between their members in order to raise the price of medical consultations

The OFT’s report into medicines distribution in the UK

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • December 20 2007

On 11 December 2007, the Office of Fair Trading (“OFT”) published its long awaited report into the distribution of medicines in the UK

Commission pharma sector enquiry and initiation of formal proceedings against Servier and others

  • Bird & Bird
  • -
  • European Union
  • -
  • July 17 2009

On 8 July 2009, as this update was being finalised, the European Commission published its final report on its inquiry into the pharmaceutical sector

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy